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Abstract
Background:  Antimicrobial peptides are found in all kingdoms of life. During the evolution of
multicellular organisms, antimicrobial peptides were established as key elements of innate immunity. Most
antimicrobial peptides are thought to work by disrupting the integrity of cell membranes, causing pathogen
death. As antimicrobial peptides target the membrane structure, pathogens can only acquire resistance by
a fundamental change in membrane composition. Hence, the evolution of pathogen resistance has been a
slow process. Therefore antimicrobial peptides are valuable alternatives to classical antibiotics against
which multiple drug-resistant bacteria have emerged. For potential therapeutic applications as antibiotics
a thorough knowledge of their mechanism of action is essential. Despite the increasingly comprehensive
understanding of the biochemical properties of these peptides, the actual mechanism by which
antimicrobial peptides lyse microbes is controversial.
Results: Here we investigate how Sushi 1, an antimicrobial peptide derived from the horseshoe crab
(Carcinoscorpius rotundicauda), induces lysis of Gram-negative bacteria. To follow the entire process of
antimicrobial action, we performed a variety of experiments including transmission electron microscopy
and fluorescence correlation spectroscopy as well as single molecule tracking of quantum dot-labeled
antimicrobial peptides on live bacteria. Since in vitro measurements do not necessarily correlate with the
in vivo action of a peptide we developed a novel fluorescent live bacteria lysis assay. Using fully functional
nanoparticle-labeled Sushi 1, we observed the process of antimicrobial action at the single-molecule level.
Conclusion: Recently the hypothesis that many antimicrobial peptides act on internal targets to kill the
bacterium has been discussed. Here, we demonstrate that the target sites of Sushi 1 are outer and inner
membranes and are not cytosolic. Further, our findings suggest four successive steps of the bactericidal
process: 1) Binding, mediated mainly by charged residues in the peptide; 2) Peptide association, as peptide
concentration increases evidenced by a change in diffusive behavior; 3) Membrane disruption, during which
lipopolysaccharide is not released; and 4) Lysis, by leakage of cytosolic content through large membrane
defects.
Published: 11 May 2009
BMC Biology 2009, 7:22 doi:10.1186/1741-7007-7-22
Received: 10 November 2008
Accepted: 11 May 2009
This article is available from: http://www.biomedcentral.com/1741-7007/7/22
© 2009 Leptihn et al.; licensee BioMed Central Ltd. 
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Biology 2009, 7:22 http://www.biomedcentral.com/1741-7007/7/22
Page 2 of 13
(page number not for citation purposes)
Background
The innate immune system provides the first line of
defense against invading pathogens. Amongst various
effectors, antimicrobial peptides (AMPs) which are found
in all eukaryotes [1], are potent agents against a wide
range of pathogens, including Gram-positive bacteria
(GPB) and Gram-negative bacteria (GNB), fungi and pro-
tozoa [2]. AMPs range from 9 to 54 amino acid residues in
length and are usually positively charged. Based on their
structures, cationic AMPs are divided into four major
classes: α-helical peptides, β-sheet peptides which are sta-
bilized by up to three disulfide bridges, loop structures
containing only one disulfide bridge, and extended struc-
tures with a predominance of one or more amino acids [3-
7]. While β-sheet peptides are structured in solution even
before interaction, peptides from the α-helical class exist
as disordered structures in aqueous media. Some of these
peptides, for example cecropins [8], magainins [9], and
melittins [10], become amphipathic helices upon interac-
tion with the hydrophobic membranes of bacteria.
A major component of the outer membrane of GNB is
lipopolysaccharide (LPS). When released, LPS stimulates
a strong inflammatory response in the host, which can
lead to septic shock [11-13]. The Sushi 1 (or S1) peptide
derived from Factor C of the horseshoe crab is extensively
characterized [14-20]. It is an α-helical cationic AMP,
which binds LPS with high affinity. The 34-amino acid S1
contains a motif with alternating hydrophobic and basic
residues that are thought to be important for the interac-
tion with LPS [21].
The mechanisms underlying the potent and rapid bacteri-
cidal activities of AMPs have been widely investigated [22-
29]. According to the hypothesis of self-promoted uptake,
the electrostatic attraction between the negatively charged
LPS and the cationic peptide is important for the interac-
tion of the peptides with the bacterial surface [30,31]. Cat-
ionic peptides have a higher affinity than do native
divalent cations for membrane-embedded LPS and
thereby destabilize the targeted areas, facilitating the
translocation of the peptide through the outer membrane
[32]. Once the peptide has crossed the outer membrane
and the mesh-like peptidoglycan cell wall, it is envisaged
to interact with the negatively charged surface of the cyto-
plasmic membrane. To explain the mechanism of antibac-
terial action of membrane-active AMPs, several models
have been proposed [23,24,26,27,33,34]. According to
these models, the mechanism of action is thought to be
the breakdown of membrane integrity by inducing pores
or by a detergent-like membrane disruption leading to
leakage of the cytosolic content.
Although the lipid-binding and antimicrobial effects of
AMPs have been intensively studied, the mechanisms by
which AMPs kill bacteria remain controversial. Moreover,
the dynamics of bactericidal processes are relatively
unknown. To date, most of the experiments and simula-
tions that have aimed to elucidate the bactericidal mecha-
nisms have been carried out with artificial membranes but
not with live bacteria. The drawback of this approach was
demonstrated recently by observations that leakage exper-
iments with artificial membranes are not a reliable indica-
tor for the prediction of antimicrobial activity in vivo [35].
In addition, most experiments to date have been carried
out on ensembles, which may mask heterogeneous behav-
ioral characteristics of the individual AMP molecules.
Here we report for the first time the use of a combination
of high-resolution imaging, in vivo single molecule obser-
vation, and biochemical and biological functional assays
to investigate the mechanism of action of a fully func-
tional nanoparticle-labeled antimicrobial peptide. After
treatment of bacteria with nanogold-labeled S1 and fixa-
tion, we made endpoint observations of bacterial killing
using transmission electron microscopy (TEM). Real-time
measurements of the dynamics of quantum dot-labeled
S1 on live bacteria were performed by fluorescence corre-
lation spectroscopy (FCS) and single particle tracking
(SPT). To exclude the potential unreliability of the antimi-
crobial lysis assays, we developed a live bacterial lysis
assay using Escherichia coli that expresses a fluorescent pro-
tein. The combination of a high resolution single mole-
cule imaging technique and in vivo bacterial lysis assays
have allowed us to elucidate the mechanism of action of
S1 with direct physiological relevance.
Results
Nanoparticle-labeled S1 retained its specific activity
To study S1 at a single-molecule level, we designed nano-
particle conjugates making use of the strong biotin-
streptavidin interaction. We performed a variety of tests to
be certain that conjugation of Qdot to S1 does not affect
the peptide activity (Figure 1).
Firstly, the Qdot label did not interfere with S1 interaction
with membrane phospholipids. The tryptophan residue
in S1 exhibits a characteristic blue shift in emission when
entering a non-polar environment. Unlabeled S1 showed
a 10 nm shift in anionic phospholipids, such as POPS or
POPG [36]. Similarly, the tryptophan residue in S1-Qdot
showed the same spectral shift upon interaction with lip-
ids such as POPS (Figure 1A), suggesting that S1-Qdot has
retained its ability to insert into the non-polar environ-
ment of the lipid. The control negS1 showed no spectral
shift in any of the lipids tested ((A) in Additional file 1)
demonstrating the specificity of the interaction between
S1 and the bacterial membrane lipids.BMC Biology 2009, 7:22 http://www.biomedcentral.com/1741-7007/7/22
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Qdot-peptide conjugate probe testing Figure 1
Qdot-peptide conjugate probe testing. (A) Tryptophan fluorescence emission spectra of S1 in buffer (dotted line), bound 
to Qdots (dashed line) or bound to Qdots in POPS (solid line). The samples contained either only 500 nM peptide or 500 nM 
Qdot-peptide conjugates with or without 25 μM POPS. (B) Lipopolysaccharide (LPS) neutralization assay. Recombinant Factor 
C activation assay of unlabeled S1 (open circle) or as a Qdot conjugate (open triangle). The activation of Factor C without LPS 
binding peptide is displayed with a solid square. The samples contained 125 nM S1 or S1-Qdot conjugate (1:1 ratio) or no pep-
tide. Non-conjugated Qdot as well as negS1 showed no neutralization ability in this assay. (C) Flow cytometry histogram of 
Qdot-labeled Escherichia coli. Biotin-Qdot (black line) shows very little fluorescence similar to the E. coli auto-fluorescence 
(blue line). The Qdot-negS1 labeled E. coli cells show minor fluorescence (green line). The mean fluorescent intensity for Qdot-
S1 labeled cells is clearly separated and indicates the specific staining of the cells by the probe (red). Settings: Excitation 488 
nm, emission 675 nm, counted cells 100,000. (D) Staining of E. coli with Qdot-S1 conjugate. Overlay of light microscopy and flu-
orescence images. Intense staining is observed by using Qdots-S1 peptide (left). The controls with biotin (upper right) or negS1 
(lower right) show that the unspecific binding was minimal. Total magnification: 400×.BMC Biology 2009, 7:22 http://www.biomedcentral.com/1741-7007/7/22
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Secondly, Qdot-conjugated S1 neutralizes LPS as effi-
ciently as unlabeled S1, thus showing identical biological
activity. When activated by LPS, recombinant Factor C
(rFC) cleaves a fluorogenic substrate. Neutralization of
LPS by S1 prevents rFC from cleaving the substrate. At a
concentration of less than 75 nM, S1-Qdot inhibited rFC
to the same extent as S1 (Figure 1B), suggesting that Qdot
labeling of S1 did not affect its binding and neutralization
of LPS. The control, negS1, did not neutralize LPS (Addi-
tional file 1 (B)).
Thirdly, surface plasmon resonance experiments con-
firmed binding of S1-Qdot to lipid A, the bioactive part of
LPS. The affinity of S1 and S1-Qdot towards lipid A was
9.3 × 10-9 M and 6.1 × 10-8 M, respectively. The binding is
specific because biotin-Qdot conjugates did not bind to
lipid A.
Finally, S1-Qdot specifically and strongly interacted with
GNB. Following incubation of bacteria with S1-Qdot, the
samples were extensively washed prior to Fluorescence-
activated cell sorting analysis (Figure 1C). Bacteria were
all positively stained with S1-Qdot. Interestingly, the flu-
orescence emission of S1-Qdot bound to the bacteria was
blue-shifted by 22 nm to 533 nm (Additional file 1), sim-
ilar to an observation reported for aptamer-conjugated
Qdot [37]. In addition, when E. coli were incubated with
S1-Qdot, they became highly fluorescent (Figure 1D).
With negS1-Qdot, almost no signal could be obtained
under the same conditions, similar to cells incubated with
biotin-Qdot. Taken together, these results demonstrate
that despite its size and chemical properties, the nanopar-
ticle does not significantly affect the biochemical proper-
ties and functional behavior of the conjugated S1.
S1-nanogold penetrates outer and inner membrane and 
enters the bacterial cytosol
The spatial distribution of the AMPs in and on the bacteria
was determined by TEM using nanogold-conjugated S1 as
a reporter of S1 localization. After removing unbound
particles by washing, the reaction was stopped using rea-
gents which cross-link peptides, proteins, carbohydrates,
lipids and nucleic acids. The nanoparticles were found on
the inner and outer leaflets of the inner and outer mem-
branes, as well as in the periplasmic space and cytosol of
the bacterium (Figure 2). Controls with nanogold alone
confirm that this result is due to peptide functionality. We
included negS1-nanogold as well as biotin-nanogold as
controls. In these controls, particles could not be
observed, neither free nor bound to bacteria. A further
control included the use of both components separately
(non-biotinylated S1, biotin-nanogold), not as a peptide-
nanogold conjugate. Again, in all controls, particles could
not be observed (n < 200). Therefore it can be concluded
that only particles conjugated with S1 penetrate the mem-
branes and enter the cell, demonstrating the specificity of
the S1-nanogold.
Electron microscopy of S1 nanoparticles on Escherichia coli Figure 2
Electron microscopy of S1 nanoparticles on Escherichia coli. Transmission electron microscopy micrograph of E. coli 
with negS1 (left) or S1-nanogold conjugate (middle). An ultrathin section of a cell incubated with 1 μM negS1- or S1-nanogold 
conjugate, fixed with paraformaldehyde, glutaraldehyde and osmium tetroxide. The right panel shows 2× magnified details. The 
'control' shows a membrane section of negS1-nanogold, whereas (1) and (2) are details of S1-nanogold. Nanogold particles, 
identified as electron-dense black spots (arrows), can only be found in samples containing S1-nanogold particles and are distrib-
uted on the outer and inner leaflets of both membranes, as well as in the periplasm and cytoplasm. OM: Outer membrane, IM: 
Inner membrane. Scale bar: 100 nm.BMC Biology 2009, 7:22 http://www.biomedcentral.com/1741-7007/7/22
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To quantify particle distributions, we counted particles on
or in the cells in TEM images (n = 254). When 1 μM S1
was used, approximately 77% of the particles were found
attached to the outer leaflet of the outer membrane; less
than 9% with the inner leaflet of the inner membrane; less
than 7% in the cytosol; and 8% in the periplasmic space
(Additional file 2). These results suggest that S1 binds and
penetrates the outer and inner membranes to disrupt the
lipid bilayers of both membranes, allowing particles up to
10 nm to diffuse through the membrane barrier.
S1 induces immediate leakage of bacterial cytosolic 
content without release of lipopolysaccharide molecules
To determine the kinetics of bacterial killing by S1 in real
time, we used FCS to measure leakage of green fluorescent
protein (GFP) from GFP-expressing E. coli. FCS is based
on fluorescence intensity fluctuations within a confocal
volume. From these autocorrelation functions (ACF) can
be determined which can be fitted with theoretical pre-
determined models to extract molecular parameters for
different fluorescence species [38]. In particular, by using
FCS it is possible to determine the average time a particu-
lar fluorescent species takes to traverse the confocal vol-
ume and the number of particles within this confocal
volume. The diffusion time (Td) is directly related to the
diffusion coefficient (D) since in FCS the following equa-
tion holds for diffusive processes: D·Td = constant
The number of particles in the confocal volume of each
species is proportional to their concentration and thus
changes in their relative amounts in mixtures can be deter-
mined (although the fractions determined by FCS might
not correspond to mole fractions) [39]. For our purposes,
we analyzed the fluctuation correlation of GFP in order to
Determination of green fluorescent protein release from Escherichia coli using fluorescence correlation spectroscopy Figure 3
Determination of green fluorescent protein release from Escherichia coli using fluorescence correlation spec-
troscopy. (A) Bacterial lysis assay with 500 nM S1 (solid upward triangle), 500 nM polymixin B (PMB) (solid square), no addi-
tive (open downward triangle) and negS1 (open circles) using fluorescence correlation spectroscopy (FCS). The peptide-
induced leakage of green fluorescent protein (GFP) from the cytosol was observed by recording the fluorescence correlation 
curves and fitting it after a two-particle diffusion model. Ffast is the fraction of fast diffusing particles, that is, GFP free in solution. 
The fraction of slow diffusing particles, that is, GFP enclosed within bacterial cells, is given by 1-Ffast. Note that these fractions 
are not synonymous with mole fractions, as explained in the text. The last time point for each graph represents sodium 
dodecyl sulfate (SDS)-induced leakage. In contrast to a sample with no additive, S1 and PMB induced leakage of E. coli. The con-
trol peptide negS1 induced a minor amount of leakage probably due to its high hydrophobic nature. (B) Antimicrobial peptide-
induced lipopolysaccharide (LPS) release. The supernatant of fluorescent-labeled LPS molecules on bacteria was analyzed in an 
FCS setup. The y-axis represents the fluorescence photon count rate measured in kHz, that is, thousand photon counts per 
second. The count rate is a measure of the amount of LPS released from bacteria. In contrast to PMB (solid square), S1 (solid 
upward triangle) did not induce release of LPS during lysis of E. coli. As a positive control SDS (open diamond) was added, 
which disrupted the membrane therefore releasing LPS. A negative control without detergent or AMP (open downward trian-
gle) did not cause release of LPS.
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determine AMP-induced leakage from the cytosol of E.
coli. Before addition of S1, GFP was trapped in intact bac-
teria and followed the diffusion times of the bacteria at
approximately 0.1 to 1 second. Upon lysis, cytosolic GFP
was released, showing diffusion times of only approxi-
mately 0.15 ms, that is, 103 to 104 faster than that of intact
bacteria. Using FCS, we analyzed samples after addition of
500 nM AMPs or controls, at 5-minute intervals over a 1-
hour period (Figure 3A).
At 500 nM S1, bacterial lysis started immediately after
peptide addition. ACF curves fitted with a two-particle dif-
fusion model showed that about 40% of GFP measured
was free GFP. Bacterial lysis continued to progress as the
fraction of free GFP increased steadily until a maximum of
90% was reached at about 40 min (100% corresponds to
lysis with sodium dodecyl sulfate (SDS)). Addition of 500
nM polymixin B (PMB) caused bacterial lysis in a similar
manner to S1 but with a slower temporal response. The
control negS1 showed minor lysis activity of less than
10% on average. The hydrophobic part of negS1 is identi-
cal to S1, which could explain the minor release of GFP.
In the absence of any peptide, there was no release of GFP
until SDS, a membrane-disrupting detergent, was added
(Figure 3A). These results suggest that S1, at a concentra-
tion of 500 nM, was highly active against E. coli and causes
rapid lysis of the bacteria. They also suggest that S1 as well
as PMB can cause membrane defects of at least 30 Å in
diameter in order for GFP to leak from the bacteria [40].
To determine if S1 can disrupt the outer membrane and
release LPS molecules from the lipid bilayer simultane-
ously, we labeled E. coli with a fluorescent dye on the
sugar residues of LPS. After incubation with S1, the cells
were pelleted and the supernatant was analyzed by FCS.
Significant increase in fluorescence intensity was detected
only when PMB, but not S1, was used (Figure 3B). Thus,
bacterial lysis by S1 does not result in a release of LPS, in
contrast to the action of PMB, as previously reported [41].
S1 shows concentration-dependent dynamics in movement 
and lateral, decelerated diffusion on bacterial membranes 
during lysis
We employed FCS to determine diffusion coefficients of
S1-Qdot on membranes of live bacteria throughout the
entire lysis process. S1-Qdot was incubated with immobi-
lized bacteria on a glass slide. Within 2 to 5 min following
the addition of 100 nM S1-Qdot and 400 nM unlabeled
S1, the particles diffused laterally on the membrane at D
= 0.46 μm2/s, and then gradually slowed down around
11-fold to 0.04 μm2/s after 23 min. At the end of 1 h, the
addition of SDS lysed the bacteria, releasing the AMP-
Qdot into the supernatant (Figure 4A). These particles
have D = 7.29 μm2/s which is comparable to that of free
Qdot diffusion in solution, and approximately 18 times
faster than that of bound particles (Figure 4B).
To confirm this observation, we characterized the peptide
movement using SPT. To track single particles on bacteria
we used fM (approximately 10-15) concentrations of the
S1-Qdot. On E. coli, the movement of S1-Qdot conjugates
was fast at low concentration of 10-14 M for a Qdot:pep-
tide ratio of 1:1. Figure 4A shows that the average D of a
single S1-Qdot particle on E. coli was 3.52 μm2/s. To
observe the behavior of the peptides at functionally active
concentrations, we added 1 μM unlabeled S1. The move-
ment was slowed down drastically as indicated by an
approximately 100 times decrease in diffusion coefficient
(from 3.52 μm2/s to 0.04 μm2/s) after 5 min, and to 6.67
× 10-3 μm2/s after 9 min (Figure 5A). These results show
that the dynamics of the particle change to a decelerated
diffusion. In contrast, when 500 nM unlabeled PMB was
added to fM concentrations of Qdot-PMB, the conjugated
particles on E. coli had an average D value of 0.72 μm2/s.
At a concentration of 500 nM S1, S1-Qdot showed an
average D of approximately 0.06 μm2/s, an order of mag-
nitude slower than the movement of PMB (data not
shown).
In order to characterize the peptide movement relative to
the bacterial cell, we analyzed trajectories of the particles
on E. coli. We observed that the AMP-Qdot conjugates
moved without any restriction along the bacterium (Fig-
ure 5Ba). At low peptide concentration the movement was
characterized by fast lateral movements (Figure 5Bb),
whereas the lateral movement slowed down at high pep-
tide concentrations (Figure 5Bc), indicating aggregation
of the peptide.
Discussion
After bacterial invasion, innate immune response is trig-
gered and effector molecules such as AMPs are released
and bind to their targets. Upon interaction with the mem-
brane lipids of the pathogen, S1 changes from an unstruc-
tured conformation to an α-helix. The importance of
charge-charge interaction is demonstrated by results
obtained with the control peptide negS1 in which cationic
charges have been replaced by anionic ones. The peptide
shows greatly reduced binding due to electrostatic repul-
sion which prevents the insertion of the hydrophobic part
into the lipophilic moiety of the membrane. A possible
explanation is that the initial interaction via charges is
much faster than the slower insertion into the membrane
by hydrophobic interaction. For further experiments we
used QDot-S1 conjugates, which might give rise to con-
cerns due to the large size of the probe relative to the pep-
tide. However, we performed thorough testing to confirm
functionality and demonstrated negligible influence of
the nanoparticle in our experimental setups. Using SPT weBMC Biology 2009, 7:22 http://www.biomedcentral.com/1741-7007/7/22
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S1-Qdot conjugate movement defined by fluorescence correlation spectroscopy Figure 4
S1-Qdot conjugate movement defined by fluorescence correlation spectroscopy. (A) Autocorrelation function of 
S1-Qdot conjugate on bacterial membrane (blue curve) and free in solution (green). Concentration of S1-Qdot conjugate was 
100 nM. The diffusion coefficient was between D = 4.96 × 10-3 μm2/s and 0.159 × μm2/s. (B)Diffusion of the S1-Qdot conjugate 
on the membrane over time at a total concentration of S1 of 500 nM.
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Single particle tracking of S1-Qdot conjugate Figure 5
Single particle tracking of S1-Qdot conjugate. (A) Single particle tracking of S1-Qdot conjugate. The diffusion of the S1-
Qdot particles on the membrane of Escherichia coli was analyzed at different time points and plotted against time. After addition 
of peptide to a final concentration to 1 μM, movement of the particles slowed down. (B) Movement trajectories of S1-Qdot-
conjugate on E. coli were measured. Time on trajectories correspond to the total time during the particle movement over the 
bacterium. The conjugate was tracked over its xy-path over 100 frames. The black trajectory corresponds to the peptide 
movement at low concentrations of S1 (1 × 10-14 M) whereas the red trajectory represents movement at 1 μM S1. Starting 
points were set to 0/0 (x/y) for both trajectories. (b) Before unlabeled peptide was added fast lateral diffusion can be observed. 
(c) After addition of peptide the particles show slow lateral diffusion. Data was obtained from seven independent measure-
ments.
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were able to show in real-time that S1 binds to the bacte-
rial surface and at low (fM) concentrations, travels rapidly
over the membrane. As the concentration of the peptide
increases, its movement decreases by a factor of 100. This
indicates a multimeric association of S1 and the forma-
tion of membrane-active peptide complexes as well as the
onset of lysis as shown by SPT and live bacterial lysis
assays. Interestingly, S1 shows slower diffusion compared
with PMB, which is known to act in a detergent-like man-
ner [42]. This, together with the observation that S1, in
contrast to PMB, does not release LPS from the bacteria,
indicates that the peptides act mechanistically differently.
Binding on and destruction of the outer membrane is
insufficient for killing of the bacterium since the cell wall
would resist osmotic burst. Therefore an AMP has to act
on both the outer and inner membranes. Using TEM on E.
coli, we show that binding of nanogold-S1 conjugates
occurs on both leaflets of both membranes, where most of
the particles are localized. Only minor fractions of peptide
conjugates could be found in the cytosol of the cell. A
recently discussed hypothesis that AMPs might mainly be
active against internal targets to kill the bacterium and not
the membrane seems therefore implausible for S1
[30,43].
As seen in TEM preparations using 10 nm nanogold-pep-
tide conjugate, S1 generates structural defects not less than
10 nm while penetrating both membranes through which
the cytoplasmic components of E. coli leak out, leading to
fast bacterial killing. However, there is no indication that
S1 disrupts the membrane by acting similarly to a deter-
gent or by forming well-defined pores. We can therefore
conclude that the formation of defined pores like alame-
thicin is not the case for S1 [44]. Whether the formation
of these structural defects is a general feature of AMPs or
an S1-specific mechanism remains so far unsolved, but
challenges the proposed models, pore sizes, and number
of peptides per complex.
In vivo, we envisage that the invading bacteria are not dis-
rupted but simply inactivated by lysis without release of
LPS. The dead pathogens with S1 immobilized on their
membranes are then cleared by macrophages. These
observations bear a crucial advantage for the host system
during infection since LPS release could trigger a severe
inflammatory reaction leading to septic shock [11-13].
Conclusion
To date, the exact mechanisms on how AMPs function on
live bacteria have not been studied on a single-molecule
level. The results presented here show how S1 interacts
with the membranes in the steps leading to pore forma-
tion followed by bacterial death. For the first time, the
entire process of bacterial killing by an AMP has been sys-
tematically monitored using a comprehensive set of end-
point and real-time observations. Our results establish a
temporally and spatially resolved view of the mechanism
of S1, elucidating the events taking place in a biological
context seen from a single-molecule perspective. Our find-
ings suggest four successive steps of the bactericidal proc-
ess of AMPs: binding, aggregation, membrane disruption,
but not release of LPS, and lysis of the bacterium.
We demonstrated that the antimicrobial peptide, S1,
binds to both the outer and inner membranes of GNB,
leading to leakage of the cytosolic content. On the mem-
brane, S1 shows concentration-dependent diffusive prop-
erties with reduced lateral mobility at high
concentrations. During this multimeric association event,
membrane defects of at least 10 nM are formed which are
larger than the proposed pore sizes in the literature.
In addition to our results, the newly developed nanopar-
ticle-conjugated AMPs represent useful tools for research
in the field of antimicrobial or cell-penetrating peptides.
Methods
Peptides
Sushi 1 peptide (GFKLKGMARISCLPNGQWSNFPPK-
CIRECAMVSS) was synthesized by Genemed Synthesis
Corp (San Francisco, CA, USA). S1 peptide was synthe-
sized with and without N-terminal biotinylation. A Sushi
1 mutant named negS1 was used as negative control – the
first three Lysine (K) and Arginine (R) residues were
changed to Glutamate (E) – (GFELEGMAEISCLPNG
QWSNFPPKCIRECAMVSS). NegS1 was produced as an N-
terminal biotinylated peptide. PMB nonapeptide was pur-
chased from Bedford Laboratories (Bedford, OH, USA).
Unmodified peptides were biotinylated for conjugation
by using the EZ-Link Biotinylation Kit (Pierce Biotechnol-
ogy, Rockford, IL, USA) based on a protocol for N-termi-
nal biotinylation provided by the manufacturer.
Biotinylated peptides were used for conjugation with
streptavidin on Qdots or nanogold. In general, the active
amount of peptides was achieved by adding unmodified
peptide to avoid effects of avidity. Nevertheless full activ-
ity for both the modified and unmodified peptides was
confirmed by all tests.
Transmission electron microscopy with antimicrobial 
peptide-nanogold conjugates
E. coli ATCC 25922 was grown overnight at 37°C in Muel-
ler-Hinton broth. 1 × 109 cells/ml were washed three
times with phosphate-buffered saline (PBS) and resus-
pended in the original volume in PBS. Nanogold particles
of 10 nm size (Sigma-Aldrich) were covalently linked to
streptavidin (Invitrogen), then conjugated with a 1:1 ratio
of N-terminal biotinylated S1. Non-biotinylated S1 was
added to a ratio of 1:5 (nanogold:peptide). 100 μl of thisBMC Biology 2009, 7:22 http://www.biomedcentral.com/1741-7007/7/22
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solution was mixed with 100 μl of E. coli using three dif-
ferent concentrations of peptide (125 nM, 500 nM and 1
μM). After varying incubation times (10, 30, 60 min) the
bacteria were washed twice with 1 ml PBS each, and fixed
by the addition of 2.5% glutaraldehyde and 2% para-for-
maldehyde, which cross-link proteins and peptides and
traps carbohydrates, lipids and nucleic acids in the bacte-
rium. Following that a 12-hour lipid fixation with 1%
osmium tetroxide in PBS was performed. Subsequently a
standard TEM sample protocol was followed with dehy-
dration steps before embedding in resin [45]. After micro-
tomy and transfer of the sample preparations onto
formvar copper grids, the samples were stained by uranyl
actetate (10%, 10 min) and lead citrate (1.5%, 5 min). As
controls, negS1 or biotin was used together with the nano-
gold particles. In addition, nanogold with non-bioti-
nylated S1 was used. The samples were observed with a
Philipps CM10 TEM using a primary magnification of
42,000 to 145,000. The nanogold particles were counted
to evaluate their distribution on/in the cell.
Preparation of Qdot-labeled antimicrobial peptides
8 μM Qdot655 ITK Amino (PEG) Quantum Dots (Invitro-
gen) were mixed with 1 mM bis-(sulfosuccinimidyl)
suberate (BS3, Pierce Biotechnology) dissolved in PBS (pH
7.4) in a glass vial and left at room temperature for 30
min. After buffer exchange using a desalting column
(Pierce Biotechnology) the colored eluent was collected
and incubated overnight at 4°C with a 1:1 ratio of strepta-
vidin (Pierce Biotechnology). The reaction was quenched
in 50 mM glycine, pH 7.5 for 2 h at room temperature.
The conjugate was purified from excess of streptavidin by
using ultrafiltration (100 kDa, Millipore) according to the
manufacturer's instructions, exchanging the buffer to PBS,
pH 7.5. Immediately before measurements, the streptavi-
din Qdots were incubated with biotinylated peptides for
approximately~10 min under vigorous shaking.
Fluorescence spectroscopy
Fluorescence emission spectra were recorded on a spec-
trofluorimeter (LS 50B, Perkin-Elmer) from 300 to 450
nm at room temperature. The excitation wavelength was
set to 280 nm with both the excitation and emission slit
width set to 5 nm. The spectra were baseline-corrected by
subtracting the blank spectra of the corresponding lipid
solutions without the peptide.
Lipopolysaccharide neutralization assay
The LPS neutralization was quantified by using the Pyro-
Gene kit (Lonza Inc.). The principle of this assay is the
activation of recombinant rFC by LPS. Upon activation
the enzyme hydrolyzes a fluorogenic substrate which
emits light at 440 nm when excited at 380 nm. The fluo-
rescence was recorded at 3-min intervals. Positive (LPS
only) and negative (buffer only) controls were included in
each run. From triplicate measurements, the mean values
with standard error and standard deviation were obtained
as a function of time.
Fluorescence microscopy
A commercial laser scanning confocal microscope
(FV300, Olympus) was used to examine the staining of
peptide-Qdot655 (Invitrogen) conjugates. GNB, includ-
ing Pseudomonas aeruginosa and E. coli, as well as GPB (Sta-
phylococcus aureus) were used. The bacteria were
immobilized on 0.01% Poly-L-lysine-treated glass slides
(Sigma). Then glass slides with the bacteria were washed
with 1 ml PBS (16 mM phosphate buffered saline, pH 7.4)
before 10 μl of 10 nM peptide-Qdot conjugate was added.
Before observation, a second washing step was conducted.
Fluorescence correlation spectroscopy instrumentation
The FCS system was built around a FV300 Olympus laser
scanning confocal microscope, where an additional FCS
module was coupled to the microscope. An excitation
beam of 488 nm Argon laser (100 μW, Melles Griot) was
reflected by an excitation dichroic mirror (560DCLP,
Omega, VT) and a scanning mirror, and focused by a
water immersion objective (60×, NA1.2, Olympus) into
the fluorescent sample. The emission light after the confo-
cal pinhole was focused by a lens (Achromats f = 60 mm,
Linos), and separated from the excitation light by an emis-
sion filter (645AF75, Omega, VT). It was then collected on
an active area of an avalanche photodiode (APD) in a sin-
gle-photon-counting module (SPCM- AQR-14, Pacer
Components). The transistor-to-transistor logic output
signal from the APD was processed online by an autocor-
relator (Flex02-01D, correlator.com) to obtain an experi-
mental ACF curve. Curve fitting was performed using a
self-written program in IgorPro (WaveMetrics). Further
details on FCS theory are described in Magde et al. [38].
Antimicrobial peptide-induced cell lysis assay
E. coli was transformed with the pEGFP vector (BD Bio-
science Clontech, Palo Alto, CA, USA). This vector con-
tains an ampicillin-resistance determinant and a GFP
gene. A constitutive lac promoter leads to the expression
of the GFP gene. We examined cell lysis ability of S1 by
FCS. 20 μl of 1 μM S1 was added to 20 μl of a logarithmi-
cally growing culture of GFP-expressing E. coli (5 × 107/
ml), giving a final concentration of 500 nM S1. Then, the
sample was measured using FCS over a period of 1 h at 5-
min intervals. For each sample, at least eight 30-s meas-
urements were recorded, and the mean reading was calcu-
lated. Upon cell lysis, the GFP E. coli release cytosolic GFP,
which has a smaller diffusion time (0.15 ms) than trapped
GFP, which follows the bacterial diffusion time (1 ms to 1
s). This was repeated in separate experiments with 500 nM
PMB, 500 nM negS1 and no peptide (negative control) for
comparison. The lysis concentration, which is indicativeBMC Biology 2009, 7:22 http://www.biomedcentral.com/1741-7007/7/22
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of the bacterial lysis ability of the AMPs, was determined.
At the end of 1 h, 2.5% SDS was added to lyse the bacteria.
The fraction of fast-moving particles was obtained from
fitting FCS curves with a two-particle 2-D diffusion model,
and plotted against time. According to the lysis concentra-
tions and times, SPT experiments were performed. Data
shown are averaged from four independent measure-
ments.
Lipopolysaccharide release assay
Six ml of an overnight culture of E. coli was washed three
times with PBS. After centrifugation the bacteria were con-
centrated four times, and incubated with freshly prepared
10 mM NaIO4 at 4°C for 1 h, which oxidizes molecules
such as sugars of LPS. After three more washes with PBS
the bacteria were incubated with 100 μM Alexa Fluor 555
(Invitrogen) followed by 5 h at room temperature in the
dark. Then bacteria were washed 10 times with PBS and
diluted four times into a PBS solution containing peptides
(S1, PMB) or blanks (PBS). After 10, 20, 40, 60 and 90
min, aliquots were taken and centrifuged. The superna-
tant was analyzed in an FCS setup and the fluorescence
intensity from eight measurements were averaged and
plotted against time.
Binding of AMP-Qdot probe onto bacterial membrane
Using FCS, we measured in real-time the diffusion of 100
nM S1-Qdot conjugates upon binding to the immobilized
bacteria, which have been attached to a glass slide by
0.01% poly-L-lysine. The FCS system was calibrated with
1 nM fluorescein (Invitrogen) before each experiment to
ensure the proper calibration of the instrument. Then
non-biotinylated S1 was added to a final concentration of
500 nM S1. At the end of 1 h, 2.5% SDS was added to lyse
the bacteria. The diffusion time of conjugates moving
along the membrane and when they were finally diffusing
freely in solution were calculated from the ACF curves.
Measurements were done in sets of eight 30-s readings.
Single particle tracking
SPT was performed on a modified EMCCD camera (Cas-
cade: 512B, Photometrics)-coupled inverted epifluores-
cence microscope (Axiovert 200 M, Carl Zeiss) in total
internal reflection fluorescence mode. Laser light from a
532 nm diode-pumped solid state laser (Calypso, Cobolt,
PhotoniTech) at 5 to 6 mW was used for excitation, and
the emission filter used 645AF75. 10 nM S1 was incu-
bated for 5 min in a 1:1 ratio with Qdot655, and then the
mixture was serial-diluted to 1 × 10-14 M.  E. coli was
immobilized onto glass slide with 0.01% poly-L-lysine,
and washed in PBS. Ten microliters of 1 × 10-14 M S1-Qdot
was then added to the bacteria and incubated for 2 min.
Unbound S1-Qdot particles were removed by washing
with PBS before measurements. 1 μM unlabeled S1 was
then added to the sample. Bacteria were located by differ-
ential interference contrast microscopy. Movie streams
(100 frames, recording time 6 ms/frame with 5 ms expo-
sure time and 1 ms read out time) of S1-Qdot were
recorded in 80 × 80 pixel regions of interest at 5-min inter-
vals over a 1-h period. Trajectories of S1-Qdot were
tracked using Metamorph software (Universal Imaging
Corp.), and mean squared displacement values were cal-
culated from the x- and y-coordinates.
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